enteroviru
infect
one
common
caus
factor
hand
foot
mouth
diseas
hfmd
may
lead
diseas
sever
morbid
high
rate
neurolog
disord
asept
mening
acut
flaccid
paralysi
fatal
neurogen
pulmonari
edema
nonenvelop
singlestrand
posit
sens
rna
viru
taxonom
classifi
within
enteroviru
speci
enteroviru
genu
famili
picornavirida
first
isol
stool
infant
fatal
enceph
california
sinc
initi
describ
outbreak
infect
occur
period
throughout
world
includ
malaysia
singapor
japan
australia
unit
state
germani
taiwan
mainland
china
howev
mechan
underpin
pathogenesi
infect
associ
complic
still
remain
larg
unknown
base
clinic
manifest
anim
experi
one
hypothesi
inflammatori
respons
character
cytokin
storm
induc
infect
subsequ
lead
patholog
chang
central
nervou
system
cn
result
disrupt
cn
stabil
antiviru
infect
often
domin
respons
studi
show
proinflammatori
factor
includ
tumor
necrosi
factor
alpha
increas
serum
cerebrospin
fluid
fatal
case
besid
coemerg
cell
recent
observ
sever
viral
infect
coronaviru
human
immunodefici
viru
simian
immunodefici
viru
respiratori
syncyti
viru
cytomegaloviru
one
studi
show
subset
involv
immunopathogenesi
infect
concentr
sera
infect
children
increas
compar
control
respons
character
product
signatur
cytokin
cytokin
famili
includ
six
member
among
central
player
adapt
immun
respons
share
homolog
consid
inflammatori
cytokin
sinc
induc
mani
proinflammatori
cytokin
chemokin
gene
locat
chromosom
one
lab
previou
studi
show
associ
protect
enceph
studi
aim
identifi
whether
gene
polymorph
associ
suscept
sever
infect
chines
han
popul
patient
recruit
pediatr
depart
affili
hospit
qingdao
univers
qingdao
women
children
hospit
china
qingdao
area
small
number
surround
area
qingdao
present
studi
includ
patient
healthi
control
present
checkup
period
infect
diagnos
revers
transcript
polymeras
chain
reaction
rtpcr
rna
extract
throat
swab
stool
specimen
cerebrospin
fluid
csf
tissu
fluid
collect
patient
day
admiss
control
children
contact
individu
confirm
evalu
rna
extract
throat
swab
stool
specimen
patient
control
receiv
gener
physic
necessari
laboratori
examin
hfmd
diagnos
senior
physician
special
train
accord
hfmd
clinic
diagnosi
treatment
guidelin
publish
chines
ministri
health
base
guidelin
mild
case
character
herpet
stomat
rash
hand
feet
without
fever
case
clinic
diagnos
hfmd
one
follow
symptom
defin
sever
case
persist
high
fever
muscl
weak
limb
jitter
spasm
disord
conscious
weak
absent
tendon
reflex
posit
mening
stimul
pallor
tachycardia
impair
peripher
circul
abnorm
blood
pressur
dyspnea
irregular
breath
rhythm
cyanosi
increas
lung
wet
rale
sign
lung
consolid
high
low
peripher
blood
leukocyt
count
significantli
elev
blood
glucos
mmoll
abnorm
chest
xray
peripher
blood
sampl
collect
steril
vial
contain
ethylenediaminetetraacet
acid
edta
blood
cell
plasma
separ
kept
use
describ
previous
fluoresc
quantit
revers
transcriptas
polymeras
chain
reaction
qrtpcr
use
detect
number
copi
viral
rna
present
sampl
total
rna
extract
ul
variou
swab
sampl
use
rnaiso
plu
kit
takara
dalian
china
accord
manufactur
instruct
next
total
rna
revers
transcrib
random
hexam
use
revers
transcript
kit
thermo
scientif
cdna
subject
quantit
pcr
ul
reaction
mixtur
thermo
scientif
dynamo
sybr
green
qrtpcr
kit
primer
nucleotid
nucleotid
condit
consist
denatur
step
min
cycl
thermal
cycl
seri
dilut
contain
copiesul
dna
fragment
deriv
use
make
standard
curv
calcul
copi
number
viral
rna
variou
sampl
quantit
realtim
rtpcr
perform
use
system
genet
dna
extract
white
blood
cell
use
commerci
kit
qiagen
accord
manufactur
protocol
describ
previous
use
improv
multiplex
ligat
detect
reaction
imldr
techniqu
develop
geneski
biotechnolog
inc
shanghai
china
detect
polymorph
gene
product
size
bp
bp
gene
polymorph
analysi
pcr
perform
use
forward
primer
gaggggaggacccttcctga
revers
primer
gcccaccttttctccccaag
gene
polymorph
analysi
pcr
perform
use
forward
primer
ggagaaaagtgggcaggagaa
revers
primer
cataactcccacagccctcgtta
pcr
program
min
cycl
min
cycl
min
follow
min
hold
pcr
product
purifi
digest
u
shrimp
alkalin
phosphatas
h
min
ligat
reaction
contain
ul
ligas
buffer
ul
taq
dna
ligas
ul
probe
mixtur
ul
purifi
pcr
product
mixtur
doubl
connect
reaction
site
contain
two
end
allel
specif
probe
end
allel
specif
probe
allel
specif
connect
product
distinguish
fluoresc
differ
loci
distinguish
differ
length
ad
end
allel
specif
probe
probe
follow
ttccgcgttcggactgatatcacaccttttgtcttggagcagg
tacggttattcgggctcctgtcacaccttttgtcttggagcaga
ccataaagaaattctttgatttaccttgtct
tttttttttttttt
ttccgcgttcggactgatat
tgaagctgcttcaggaaacaatgg
tacggttattcgggctcctgt
tgaagctgcttcaggaaacaacga
caaaaaagctaaataccctaacaaaagatatgc
tttttttttttttt
ligat
cycl
program
consist
cycl
min
min
hold
ligat
product
analyz
use
genet
analyz
abi
raw
data
analyz
use
genemapp
appli
biosystem
usa
plasma
concentr
assess
use
commerci
elisa
kit
ray
biotech
inc
usa
human
accord
manufactur
guidelin
sampl
assay
duplic
valu
within
linear
portion
standard
curv
data
test
chisquar
test
degre
fit
equilibrium
hwe
observ
expect
valu
frequenc
genotyp
allel
compar
group
patient
mild
case
sever
case
use
chisquar
test
associ
gene
polymorph
risk
sever
diseas
evalu
calcul
odd
ratio
or
confid
interv
ci
use
logist
regress
effect
genotyp
infect
evalu
use
statist
nonnorm
distribut
paramet
data
express
median
valu
percentil
valu
level
analyz
oneway
analysi
varianc
anova
follow
tukey
multipl
comparison
test
graphpad
prism
softwar
san
diego
ca
usa
use
statist
analys
signific
set
pvalu
examin
group
children
includ
male
femal
age
year
mild
case
sever
case
includ
case
enceph
one
sever
case
die
genotyp
frequenc
group
obey
equilibrium
p
genotyp
distribut
allel
frequenc
children
healthi
control
present
tabl
consid
gene
polymorph
genotyp
distribut
control
group
cc
ct
tt
similar
patient
cc
ct
tt
p
frequenc
c
allel
control
group
compar
respect
infect
patient
p
addit
sever
case
significantli
higher
frequenc
tt
genotyp
mild
case
p
mild
case
genotyp
distribut
cc
ct
tt
cc
ct
tt
sever
case
similarli
allel
observ
significantli
higher
frequenc
sever
case
mild
case
vs
ci
p
furthermor
genotyp
tt
allel
case
enceph
also
frequent
observ
mild
case
vs
p
vs
ci
p
howev
polymorph
differ
observ
genotyp
distribut
allel
frequenc
control
patient
p
p
statist
differ
genotyp
distribut
allel
frequenc
compar
sever
case
p
p
case
enceph
p
p
mild
case
next
observ
effect
gene
polymorph
sever
infect
shown
tabl
obviou
differ
differ
genotyp
infect
patient
relat
durat
fever
p
white
blood
cell
wbc
count
p
creactiv
protein
crp
level
p
blood
glucos
bg
concentr
p
detail
provid
follow
median
durat
fever
day
cc
day
ct
day
tt
median
wbc
count
cc
ct
tt
median
crp
level
mgl
cc
mgl
ct
mgl
tt
median
bg
concentr
mmoll
cc
mmoll
ct
mmoll
tt
howev
signific
differ
differ
genotyp
infect
patient
regard
gender
age
alanin
aminotransferas
alt
aspart
aminotransferas
ast
cardiac
creatin
kinasemb
ckmb
level
viral
load
serum
level
significantli
differ
among
sever
case
mild
case
healthi
control
pgml
fig
level
measur
genotyp
infect
children
sever
case
infect
data
show
level
patient
tt
pgml
genotyp
ct
pgml
genotyp
significantli
higher
cc
genotyp
pgml
fig
howev
signific
differ
concentr
among
genotyp
mild
case
infect
fig
infect
result
sever
sever
complic
high
mortal
disabl
children
numer
factor
influenc
immun
respons
infect
recent
year
mani
associ
studi
host
genet
factor
infect
perform
lab
previous
demonstr
polymorph
gene
cptii
associ
suscept
andor
sever
infect
cytokineschemokin
receptor
necessari
effici
inflammatori
respons
locat
promotor
region
previou
studi
report
gene
polymorph
involv
sever
diseas
asthma
tuberculosi
date
studi
perform
gene
polymorph
aim
identifi
whether
gene
polymorph
associ
suscept
sever
infect
chines
han
popul
signific
differ
found
infect
children
healthi
control
term
distribut
genotyp
allel
data
also
reveal
gene
polymorph
associ
sever
infect
compar
sever
case
enceph
mild
case
howev
found
frequenc
tt
genotyp
allel
markedli
overrepres
sever
case
includ
case
enceph
compar
mild
case
healthi
control
suggest
polymorph
might
associ
sever
infect
chines
han
popul
result
consist
report
result
asthma
south
indian
popul
tuberculosi
chines
popul
epidemiolog
studi
show
young
age
male
gender
high
wbc
count
prolong
high
fever
high
bg
concentr
high
crp
level
key
factor
associ
sever
infect
patient
addit
factor
crp
wbc
also
common
indic
inflammatori
respons
studi
found
significantli
higher
wbc
count
crp
level
bg
concentr
longer
durat
fever
infect
subject
tt
genotyp
howev
differ
organ
function
paramet
alt
ast
ckmb
among
differ
genotyp
infect
taken
togeth
data
indic
gene
polymorph
involv
inflammatori
process
follow
infect
actual
mechan
gene
polymorph
affect
sever
infect
unclear
follow
postul
may
plausibl
may
play
immunopatholog
role
tissu
damag
viral
infect
accumul
data
suggest
augment
product
proinflammatori
cytokin
includ
well
chemokin
includ
matrix
metalloproteinas
result
recruit
mobil
activ
immun
cell
lead
sever
inflammatori
process
tissu
damag
addit
central
nervou
system
cn
human
cell
could
promot
blood
brain
barrier
bbb
disrupt
cn
inflamm
coexpress
granzym
b
promot
recruit
addit
lymphocyt
huppet
et
al
also
report
induc
bbb
disrupt
format
reactiv
oxygen
speci
ro
nad
p
h
oxidas
xanthin
oxidas
subsequ
respons
disrupt
downregul
tight
junction
molecul
activ
endotheli
contractil
machineri
furthermor
rhesu
monkey
infant
model
upregul
sustain
peripher
blood
ror
proven
key
transcript
factor
differenti
cell
releas
chen
et
al
reveal
frequenc
cell
peripher
blood
concentr
level
express
acidrel
orphan
nuclear
receptor
gamma
ror
significantli
increas
infect
children
base
previou
public
data
explor
whether
relationship
polymorph
serum
level
patient
result
show
significantli
higher
serum
level
patient
tt
genotyp
sever
case
infect
sinc
locat
promotor
region
find
suggest
gene
polymorph
could
affect
express
condit
could
conclud
allel
like
increas
sever
infect
incid
enceph
upregul
serum
level
could
induc
higher
amount
upstream
inflammatori
mediat
bbb
disrupt
perhap
one
pathogen
mechan
occur
follow
infect
multicent
studi
larger
sampl
size
multipl
ethnic
group
requir
determin
effect
genet
variant
gene
studi
strongli
demonstr
gene
polymorph
associ
suscept
sever
infect
enceph
chines
han
popul
studi
need
identifi
exact
mechan
underli
involv
gene
pathogenesi
infect
